Marilys Corbex

Marilys Corbex

Auto-generated profile, based on publicly available information

Marilys Corbex

World Health Organization, Regional Office for Europe, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Cancer Nursing
Verified
Journal Article
Closed access
JMJoanne MA McEwan
Joanne MA McEwan
CUCarol Underwood
Carol Underwood
MCMarilys Corbex
Marilys Corbex
Background: In developing countries, breast cancer is generally diagnosed late. Two companion quantitative studies found that health system shortages were a major cause of delayed diagnosis together with poor health literacy. Yet, patients’ perceptions regarding the delays were missing. Objective: We conducted a qualitative study to deepen our understanding of women’s experiences with diagnosis and treatment delays and highlight nuances not identifiable in the quantitative studies. Interventions/Methods: Fifteen women recruited from the quantitative study were interviewed. Information on diagnosis/treatment delays collected in the quantitative study constituted the basis for the selection of participants, the aim being to ensure a maximum of variability in the types of delays. Results: In addition to women’s health literacy challenges, which likely resulted from the interactions of individual, interpersonal, and systemic factors, barriers attributable to healthcare system weaknesses and financial constraints were revealed to be key factors. Conclusions: To reduce late-stage diagnosis, tackling women’s “lack of breast cancer awareness” is far from sufficient. Although the majority of health professionals are not in a position to address structural and policy barriers, it is nonetheless important for them to be cognizant of these barriers so that they can better advise and guide their patients. Implications for Practice: Our study aimed to provide a deeper understanding of the social, cultural, and structural barriers patients face in Egypt. Such knowledge should help nurses and other health professionals develop a nonjudgmental, compassionate, and perceptive approach to care.

5 August 2023 in Journal of Cancer Policy
Verified
Journal Article
Open access
AZAriana Znaor
Ariana Znaor
ARAnton Ryzhov
Anton Ryzhov
MLMaría Lasierra Losada
María Lasierra Losada
ACAndre Carvalho
Andre Carvalho
VSVitaly Smelov
Vitaly Smelov
MCMarilys Corbex
Marilys Corbex
Eastern Europe and Central Asia (EECA) countries have higher cervical and breast cancer mortality rates and later stage at diagnosis compared with the rest of WHO European Region. The aim was to explore current early detection practices including "dispensarization" for breast and cervix cancer in the region. A questionnaire survey on early detection practices for breast and cervix cancer was sent to collaborators in 11 countries, differentiating services in the primary health setting, and population-based programs. Responses were received from Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, the Russian Federation (Arkhangelsk, Samara and Tomsk regions), Tajikistan, Ukraine, and Uzbekistan. All countries but Georgia, Kyrgyzstan, and the Russian Federation had opportunistic screening by clinical breast exam within "dispensarization" program. Mammography screening programs, commonly starting from age 40, were introduced or piloted in eight of nine countries, organized at national oncology or screening centres in Armenia, Belarus and Georgia, and within primary care in others. Six countries had "dispensarization" program for cervix cancer, mostly starting from the age 18, with smears stained either by Romanowsky-Giemsa alone (Belarus, Tajikistan and Ukraine), or alternating with Papanicolaou (Kazakhstan and the Russian Federation). In parallel, screening programs using Papanicolaou or HPV test were introduced in seven countries and organized within primary care. Our study documents that parallel screening systems for both breast and cervix cancers, as well as departures from evidence-based practices are widespread across the EECA. Within the framework of the WHO Initiatives, existing opportunistic screening should be replaced by population-based programs that include quality assurance and control.

1 January 2026 in Glasnik javnog zdravlja
Verified
Journal Article
Open access
PDF file
MPMinttu Palsola
Minttu Palsola
TLTiina Likki
Tiina Likki
VSVeerle Snijders
Veerle Snijders
MCMarilys Anne Corbex
Marilys Anne Corbex
LLLosada María Lasierra
Losada María Lasierra
BCBenjamin Curtis
Benjamin Curtis
Population-based cancer screening programmes can significantly reduce cervix, breast and colorectal cancer mortality and morbidity. While many countries have set up screening programs for these cancers, people do not always use them. It is vital to understand why people do (not) get screened to better plan effective interventions. This paper presents a rapid review of research to identify (1) common barriers and drivers to undergoing screening and (2) intervention components used to increase screening rates. Selection criteria for the review included English-language studies published 2000-2024. To be included for barriers and drivers of cancer screening attendance, studies had to address the factors why people do (not) attend screenings. To be included for interventions, studies had to assess interventions aiming to increase screening. Quantitative and qualitative studies were eligible. The research presented here focuses primarily though not exclusively on evidence from the WHO European Region. Barriers and drivers are categorised according to the COM-B model, namely capability, opportunity, and motivation-related factors. Key capability barriers included limited awareness, low health literacy, and forgetfulness; motivational barriers included negative beliefs, fatalism, and emotional factors such as fear, shame, or disgust; opportunity-related barriers encompassed cost, access constraints, time limitations, and sociocultural stigma. Drivers included perceived benefits, high self-efficacy, supportive provider communication, and social encouragement. Effective interventions were typically multicomponent, combining educational and access-enhancing elements. Educational strategies were most successful when interactive, culturally tailored, and skill-focused. Invitations and reminders, particularly personalised, physician-signed, or opt-out formats, improved attendance. Organisational changes-such as designated screening clinics, nonphysician-led delivery, and quality improvement systems-consistently enhanced uptake. Patient navigation and community-based approaches were beneficial for underserved groups. Home-testing facilitated colorectal and cervical screening participation when logistical barriers were minimised. Cancer screening uptake is shaped by intertwined behavioural, structural, and cultural factors. Interventions that address multiple COM-B domains-improving knowledge, motivation, accessibility, and cultural appropriateness-show the greatest promise. Tailoring strategies to local contexts and population needs is critical to achieving equitable screening coverage and reducing preventable cancer burden.